Here’s Why Acutus Medical Shares Are Falling
Acutus Medical Inc (NASDAQ: AFIB) shares are trading lower by 20.8% at $1.53 after the company reported worse-than-expected fourth-quarter EPS results and issued first-quarter sales guidance below analyst estimates.
5 Stocks To Watch For March 31, 2022
Some of the stocks that may grab investor focus today are:
Acutus Medical: Q4 Earnings Insights
Acutus Medical (NASDAQ:AFIB) reported its Q4 earnings results on Wednesday, March 30, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings Outlook For Acutus Medical
Acutus Medical (NASDAQ:AFIB) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement.
Analysts estimate that Acutus Medical will report an earnings per share (EPS) of $-0.83.
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
The Daily Biotech Pulse: AbbVie’s Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Acutus Medical’s Earnings Outlook
Acutus Medical (NASDAQ:AFIB) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement.
Analysts estimate that Acutus Medical will report an earnings per share (EPS) of $-0.83.